VanEck Vectors Financial Ratios

VanEck Vectors Biotech ETF -- USA Etf  

USD 128.6  0.55  0.43%

We advise you to exercise VanEck Vectors fundamental analysis to see if markets are presently mispricing the entity. In other words you can harness it to find out if VanEck Vectors Biotech is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. . We found eleven available drivers for VanEck Vectors Biotech ETF which can be compared to its competition. Please use VanEck Vectors One Year Return and Net Asset to make a decision on weather VanEck Vectors Biotech is priced fairly. Use VanEck Vectors to protect against small markets fluctuations. The etf experiences normal downward trend and little activity. Check odds of VanEck Vectors to be traded at $127.31 in 30 days

VanEck Vectors Company Summary

VanEck Vectors competes with Health Care, iShares Nasdaq, Vanguard Health, SPDR SP, and ISHARE DJ. The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index. The fund normally invests at least 80 percent of its total assets in securities that comprise the fund benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

VanEck Vectors Net Asset vs Price to Earning

VanEck Vectors Biotech ETF is rated below average in net asset as compared to similar ETFs. It is fourth largest ETF in price to earning as compared to similar ETFs . The ratio of Net Asset to Price to Earning for VanEck Vectors Biotech ETF is about  33,495,470 

VanEck Vectors Biotech Systematic Risk

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on VanEck Vectors Biotech correlated with the market. If Beta is less then 0 VanEck Vectors generally moves in the opposite direction as compared to the market. If VanEck Vectors Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one VanEck Vectors Biotech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of VanEck Vectors is generally in the same direction as the market. If Beta > 1 VanEck Vectors moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.
< 1% 

Chance of Financial Distress

VanEck Vectors Biotech ETF has less than 1 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Compare

Compare VanEck Vectors To Peers
Jason Callan Van Eck ETF Portfolio Manager
Kevin Ritter Van Eck ETF Portfolio Manager
Wilcox Chan Van Eck ETF Portfolio Manager
Ferian Juwono Van Eck ETF Portfolio Manager
More Executives

Opportunity Range

January 17, 2018 Opportunity Range